Literature DB >> 7274630

Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.

E Suzuki, M Okada.   

Abstract

The metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) was studied in the rat, to investigate the possibility of a relationship between urinary metabolites and organotropic carcinogenicity to the urinary bladder of this N-nitrosamine. The principal urinary metabolite of BBN was identified as N-butyl-N-(3-carboxypropyl)nitrosamine (BCPN). Several minor metabolites characterized were transformation products of BCPN formed by beta-oxidation according to the Knoop mechanism, i.e., N-butyl-N-(2-hydroxy-3-carboxy-propyl)nitrosamine, N-butyl-N-(carboxymethyl)nitrosamine and N-butyl-N-(2-oxopropyl)nitrosamine; glucuronic acid conjugates of BBN and BCPN were also detected. No BBN was detected in the urine. A possible correlation of the urinary excretion of BCPN with selective induction of bladder tumors by BBN in rats is discussed in relation to the carcinogenic action of BCPN.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7274630

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  3 in total

Review 1.  Understanding the gender disparity in bladder cancer risk: the impact of sex hormones and liver on bladder susceptibility to carcinogens.

Authors:  Yuesheng Zhang
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2013       Impact factor: 3.781

Review 2.  Metabolic Activation and DNA Interactions of Carcinogenic N-Nitrosamines to Which Humans Are Commonly Exposed.

Authors:  Yupeng Li; Stephen S Hecht
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

3.  Inhibitory effect of ergosterol on bladder carcinogenesis is due to androgen signaling inhibition by brassicasterol, a metabolite of ergosterol.

Authors:  Yasuharu Yazawa; Nobutomo Ikarashi; Motohiro Hoshino; Hironori Kikkawa; Fumiyo Sakuma; Kiyoshi Sugiyama
Journal:  J Nat Med       Date:  2020-06-01       Impact factor: 2.343

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.